You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy
|
|---|---|
| Published in |
Annals of Clinical Microbiology and Antimicrobials, December 2021
|
| DOI | 10.1186/s12941-021-00491-2 |
| Pubmed ID | |
| Authors |
Yusri Taha, Hayley Wardle, Adam B. Evans, Ewan R. Hunter, Helen Marr, Wendy Osborne, Matthew Bashton, Darren Smith, Shirelle Burton-Fanning, Matthias L. Schmid, Christopher J. A. Duncan |
X Demographics
The data shown below were collected from the profiles of 128 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 20 | 16% |
| United Kingdom | 7 | 5% |
| Spain | 6 | 5% |
| France | 3 | 2% |
| Sweden | 2 | 2% |
| Netherlands | 2 | 2% |
| Belgium | 2 | 2% |
| Germany | 2 | 2% |
| India | 1 | <1% |
| Other | 12 | 9% |
| Unknown | 71 | 55% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 113 | 88% |
| Practitioners (doctors, other healthcare professionals) | 9 | 7% |
| Scientists | 5 | 4% |
| Science communicators (journalists, bloggers, editors) | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 65 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 8 | 12% |
| Student > Ph. D. Student | 6 | 9% |
| Student > Bachelor | 5 | 8% |
| Student > Master | 3 | 5% |
| Student > Postgraduate | 2 | 3% |
| Other | 6 | 9% |
| Unknown | 35 | 54% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 9 | 14% |
| Psychology | 3 | 5% |
| Immunology and Microbiology | 3 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Neuroscience | 2 | 3% |
| Other | 9 | 14% |
| Unknown | 37 | 57% |
Attention Score in Context
This research output has an Altmetric Attention Score of 76. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2024.
All research outputs
#577,667
of 25,775,807 outputs
Outputs from Annals of Clinical Microbiology and Antimicrobials
#7
of 682 outputs
Outputs of similar age
#14,883
of 519,215 outputs
Outputs of similar age from Annals of Clinical Microbiology and Antimicrobials
#1
of 12 outputs
Altmetric has tracked 25,775,807 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 682 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 519,215 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.